Wayne S DeVeydt
CIK 1321392 · Chief Financial Officer · last filed 2026-06-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.01M
Companies
8
Total Filings
116
Lifetime Open-Market Net
-$78.96M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNH | Chief Financial Officer | 19,778 | $428.79 | $8.48M | $0 | 6 | 2026-06-25 |
| CENTENE CORP (CNTE) Delisted | Director | 19,523 | — | — | $0 | 19 | 2025-07-02 |
| SGRY | Exec Chairman of the Board | 105,203 | $15.58 | $1.64M | -$9.79M | 19 | 2025-03-25 |
| NI | Director | 35,480 | $45.73 | $1.62M | $0 | 7 | 2021-05-26 |
| Myovant Sciences Ltd. (MYOV) Delisted | Director | — | $26.98 | — | $0 | 2 | 2017-10-20 |
| ANTX | EVP & Chief Financial Officer | 57,957 | $4.70 | $272.4K | -$1.00M | 3 | 2016-03-04 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Financial Officer | 82,126 | $482.58 | $39.63M | -$18.37M | 3 | 2015-04-08 |
| Elevance Health, Inc. (WLP) Delisted | EVP & Chief Financial Officer | 128,442 | — | — | -$49.80M | 27 | 2014-11-12 |
Recent Filings · Page 3 of 12
116 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-19 | SGRY | Notice (144) | −10,613 | -$234.5K | EDGAR |
| 2025-09-18 | SGRY | Notice (144) | −150,000 | -$3.29M | EDGAR |
| 2025-09-17 | SGRY | Notice (144) | −85,785 | -$1.87M | EDGAR |
| 2025-09-16 | SGRY | Notice (144) | −25,000 | -$541.5K | EDGAR |
| 2025-09-12 | SGRY | Notice (144) | −28,700 | -$628.9K | EDGAR |
| 2025-09-11 | SGRY | Notice (144) | −100,000 | -$2.20M | EDGAR |
| 2025-09-09 | CNC | Notice (144) | −10,775 | -$314.5K | EDGAR |
| 2025-09-08 | SGRY | Notice (144) | −2,014 | -$45.2K | EDGAR |
| 2025-09-05 | SGRY | Notice (144) | −25,000 | -$563.7K | EDGAR |
| 2025-09-04 | SGRY | Notice (144) | −25,000 | -$562.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.